Smith & Nephew (MEX:SN1 N) 5-Year Share Buyback Ratio : 0.30% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Smith & Nephew 5-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Smith & Nephew's current 5-Year Share Buyback Ratio was 0.30%.

MEX:SN1 N's 5-Year Share Buyback Ratio is ranked better than
90% of 660 companies
in the Medical Devices & Instruments industry
Industry Median: -3.8 vs MEX:SN1 N: 0.30

Competitive Comparison of Smith & Nephew's 5-Year Share Buyback Ratio

For the Medical Devices subindustry, Smith & Nephew's 5-Year Share Buyback Ratio, along with its competitors' market caps and 5-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Smith & Nephew's 5-Year Share Buyback Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Smith & Nephew's 5-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Smith & Nephew's 5-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Smith & Nephew 5-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from five years ago to the current year. The annualized percentage change is calculated with least-square regression based on the latest six years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Smith & Nephew (MEX:SN1 N) 5-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Smith & Nephew 5-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Smith & Nephew's 5-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Smith & Nephew Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Smith & Nephew PLC (MEX:SN1 N) » Definitions » 5-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

SNNUF:USA SNN:USA SNl:UK SN.:UK NPW1:Germany

Address

Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE

Website

https://www.smith-nephew.com

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew Headlines

No Headlines